According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM ) is $87.68 Million USD. an increase over the revenue in the year 2023 that were of $84.81 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.